These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Theophylline pharmacokinetics in adolescent females following coadministration of oral contraceptives. Koren G; Chin TF; Correia J; Tesoro A; MacLeod SM Clin Invest Med; 1985; 8(3):222-6. PubMed ID: 4042465 [TBL] [Abstract][Full Text] [Related]
25. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use. Burkman RT; Fisher AC; LaGuardia KD J Reprod Med; 2007 Nov; 52(11):1030-4. PubMed ID: 18161401 [TBL] [Abstract][Full Text] [Related]
26. [Risk-benefit evaluation of the "micropill" is positive. Results of a multicenter study with Trinovum]. Feldmann HU Gynakol Rundsch; 1986; 26 Suppl 1():43-56. PubMed ID: 3539717 [No Abstract] [Full Text] [Related]
27. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles]. Bilotta P; Favilli S Minerva Ginecol; 1987 Dec; 39(12):855-69. PubMed ID: 3329705 [No Abstract] [Full Text] [Related]
28. Rationale for a triphasic oral contraceptive. Pasquale SA J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with a new norgestimate-containing oral contraceptive. Huber J Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378 [TBL] [Abstract][Full Text] [Related]
30. [Clinical experience with two low dosage estrogen progestogen preparations (SH 7.1122 and SH B 259 AB)]. Leone U; Di Girolamo V Minerva Ginecol; 1980 Sep; 32(9):791-800. PubMed ID: 7012684 [TBL] [Abstract][Full Text] [Related]
31. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given? Edelman AB; Koontz SL; Nichols MD; Jensen JT Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938 [TBL] [Abstract][Full Text] [Related]
32. Urinary unconjugated cortisol in normally menstruating women and during estrogen-gestagen treatment. Felding C; Mikkelsen AL; Birch CD Acta Obstet Gynecol Scand; 1986; 65(6):547-50. PubMed ID: 3799149 [TBL] [Abstract][Full Text] [Related]
33. Clinical experience with a new norgestimate-containing oral contraceptive. Huber J Int J Fertil; 1992; 37 Suppl 1():47-53. PubMed ID: 1347520 [TBL] [Abstract][Full Text] [Related]
34. [Clinical study of the use of a new tri-phasic pill]. Giobbe C; Piacentino R; Marchino GL; Zaccheo F; Cellura A; Ferrara L; Mazza O; Caccuri D; Condello V; Grio R Minerva Ginecol; 1990 Nov; 42(11):463-6. PubMed ID: 2080034 [TBL] [Abstract][Full Text] [Related]
35. Vitreous haemorrhage in a 19-year-old Japanese woman using an oral contraceptive. Higa A; Ayaki M; Nishihara H; Inoue T; Ishida Y; Yaguchi S; Tsuda G; Saotome T Acta Ophthalmol Scand; 2004 Apr; 82(2):244-6. PubMed ID: 15043555 [No Abstract] [Full Text] [Related]
36. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059 [TBL] [Abstract][Full Text] [Related]
37. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Griffith SG; Dai Y Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769 [TBL] [Abstract][Full Text] [Related]